Evidence map›Paper›PMID 34043810›Full record

ArticleCancer2021

Childhood cancer mortality trends in the Americas and Australasia: An update to 2017.

Matteo Malvezzi, Claudia Santucci, Gianfranco Alicandro, Greta Carioli, Paolo Boffetta, Karina Braga Ribeiro, Fabio Levi, Carlo La Vecchia, Eva Negri, Paola Bertuccio

Abstract read
In one paragraph

Article in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Matteo MalvezziDepartment of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.ORCID 0000-0002-9110-3923
Claudia SantucciDepartment of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
Gianfranco AlicandroDepartment of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.ORCID 0000-0002-0430-2714
Greta CarioliDepartment of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
Paolo BoffettaStony Brook Cancer Center, Stony Brook University, Stony Brook, New York.
Karina Braga RibeiroDepartment of Collective Health, Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil.ORCID 0000-0002-8095-5979
Fabio LeviDepartment of Epidemiology and Health Services Research, Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Carlo La VecchiaDepartment of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.ORCID 0000-0003-1441-897X
Eva NegriDepartment of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
Paola BertuccioDepartment of Biomedical and Clinical Sciences L. Sacco, Università degli Studi di Milano, Milan, Italy.ORCID 0000-0002-2002-0127

Funding

Fondazione Italiana per la Ricerca sul Cancro 22987Ministero dell'Istruzione, dell'Università e della Ricerca RBSI1465UH
6 · The paper itself

Abstract

backgroundMarked reductions in childhood cancer mortality occurred over the last decades in high-income countries and, to a lesser degree, in middle-income countries. This study aimed to monitor mortality trends in the Americas and Australasia, focusing on areas showing unsatisfactory trends.

methodsAge-standardized mortality rates per 100,000 children (aged 0-14 years) from 1990 to 2017 (or the last available calendar year) were computed for all neoplasms and 8 leading childhood cancers in countries from the Americas and Australasia, using data from the World Health Organization database. A joinpoint regression was used to identify changes in slope of mortality trends for all neoplasms, leukemia, and neoplasms of the central nervous system (CNS) for major countries.

resultsOver the last decades, childhood cancer mortality continued to decrease by approximately 2% to 3% per year in Australasian countries (ie, Japan, Korea, and Australia), by approximately 1.5% to 2% in North America and Chile, and 1% in Argentina. Other Latin American countries did not show any substantial decrease. Leukemia mortality declined in most countries, whereas less favorable trends were registered for CNS neoplasms, particularly in Latin America. Around 2016, death rates from all neoplasms were 4 to 6 per 100,000 boys and 3 to 4 per 100,000 girls in Latin America, and 2 to 3 per 100,000 boys and approximately 2 per 100,000 girls in North America and Australasia.

conclusionsChildhood cancer mortality trends declined steadily in North America and Australasia, whereas they were less favorable in most Latin American countries. Priority must be given to closing the gap by providing high-quality care for all children with cancer worldwide. LAY SUMMARY: Advances in childhood cancer management have substantially improved the burden of these neoplasms over the past 40 years, particularly in high-income countries. This study aimed to monitor recent trends in America and Australasia using mortality data from the World Health Organization. Trends in childhood cancer mortality continued to decline in high-income countries by approximately 2% to 3% per year in Japan, Korea, and Australia, and 1% to 2% in North America. Only a few Latin American countries showed favorable trends, including Argentina, Chile, and Mexico, whereas other countries with limited resources still lagged behind.

Indexed as

NeoplasmsAdolescentAmericasAustralasiaChildChild, PreschoolFemaleHumansInfantInfant, NewbornLatin AmericaMaleMortalityWorld Health OrganizationAmericaAsiacancerchildhoodmortalityOceaniatrends

Identifiers

PMID34043810
PMCPMC8453533

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.